GH Secretagogue Blend

CJC-1295/Ipamorelin Research Guide

CJC-1295 No DAC + Ipamorelin blend for synergistic GH secretagogue research.

What Is CJC-1295/Ipamorelin?

Combines CJC-1295 No DAC (GHRH analog) and Ipamorelin (ghrelin receptor agonist) for dual-pathway GH release.

Synergy

CJC-1295 primes via GHRH receptors. Ipamorelin activates ghrelin receptors. Together they amplify GH secretion.

Components

  • CJC-1295 No DAC (5mg) — 30 AA, CAS: 863288-34-0
  • Ipamorelin (5mg) — 5 AA, CAS: 170851-70-4

Cited Sources

  1. According to Teichman, S.L. et al. (2006). "CJC-1295 and GH/IGF-I secretion." JCEM. [PubMed]
  2. According to Raun, K. et al. (1998). "Ipamorelin, first selective GH secretagogue." Eur J Endocrinol. [PubMed]
⚖️ RESEARCH USE DISCLAIMER

Educational content for informational purposes only. Products are for in-vitro research and laboratory use only. NOT for human consumption. Not medical advice.